29
Views
43
CrossRef citations to date
0
Altmetric
Original Article

Bone Mineral Content in Patients with Crohn's Disease: A Longitudinal Study in Patients with Bowel Resections

, , , &
Pages 226-232 | Received 06 Aug 1996, Accepted 02 Oct 1996, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

R. A Van Hogezand & N. A. T. Hamdy. (2006) Skeletal morbidity in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 41:sup243, pages 59-64.
Read now
C. Schulte, A. U. Dignass, K. Mann, H. Goebell. (1999) Bone Loss in Patients with Inflammatory Bowel Disease Is Less Than Expected: A Follow-up Study. Scandinavian Journal of Gastroenterology 34:7, pages 696-702.
Read now
H. Andreassen, J. Rungby, J. F. Dahlerup & L. Mosekilde. (1997) Inflammatory Bowel Disease and Osteoporosis. Scandinavian Journal of Gastroenterology 32:12, pages 1247-1255.
Read now

Articles from other publishers (40)

Jana G. Hashash & David G. Binion. (2017) Exercise and Inflammatory Bowel Disease. Gastroenterology Clinics of North America 46:4, pages 895-905.
Crossref
Xiaojing Zhao, Changcheng Zhou, Han Chen, Jingjing Ma, Yunjuan Zhu, Peixue Wang, Yi Zhang, Haiqin Ma & Hongjie Zhang. (2017) Efficacy and safety of medical therapy for low bone mineral density in patients with Crohn disease. Medicine 96:11, pages e6378.
Crossref
J. R. Goodhand, N. Kamperidis, H. Nguyen, M. Wahed & D. S. Rampton. (2011) Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis. Alimentary Pharmacology & Therapeutics 33:5, pages 551-558.
Crossref
Yasser EZZAT & Khaled HAMDY. (2010) The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases. International Journal of Rheumatic Diseases 13:3, pages 259-265.
Crossref
Naomi Lee, Graham L. Radford-Smith, Mark Forwood, Joseph Wong & Dennis R. Taaffe. (2009) Body composition and muscle strength as predictors of bone mineral density in Crohn’s disease. Journal of Bone and Mineral Metabolism 27:4, pages 456-463.
Crossref
Bo Shen, Feza H. Remzi, Ioannis K. Oikonomou, Hong Lu, Bret A. Lashner, Jeffrey P. Hammel, Mario Skugor, Ana E. Bennett, Aaron Brzezinski, Elaine Queener & Victor W. Fazio. (2009) Risk Factors for Low Bone Mass in Patients With Ulcerative Colitis Following Ileal Pouch-Anal Anastomosis. American Journal of Gastroenterology 104:3, pages 639-646.
Crossref
Bo Shen, Feza H Remzi, Ioannis K Oikonomou, Hong Lu, Bret A Lashner, Jeffrey P Hammel, Mario Skugor, Ana E Bennett, Aaron Brzezinski, Elaine Queener & Victor W Fazio. (2009) Risk Factors for Low Bone Mass in Patients With Ulcerative Colitis Following Ileal Pouch-Anal Anastomosis. The American Journal of Gastroenterology 104:3, pages 639-646.
Crossref
L. Kallel, S. Chakroun, S. Matri, N. Ben Mustapha, S. Karoui, H. Sahli, M. Fekih, J. Boubaker, S. Sellami & A. Filali. (2009) Facteurs de risque de perte osseuse chez les patients atteints de maladie de CrohnRisk factors concerning bone loss in Crohn’s disease. Journal Africain d'Hépato-Gastroentérologie 2:4, pages 147-151.
Crossref
Letícia Helena Caldas Lopes, Vera Lucia Sdepanian, Vera Lúcia Szejnfeld, Mauro Batista de Morais & Ulysses Fagundes-Neto. (2008) Risk Factors for Low Bone Mineral Density in Children and Adolescents with Inflammatory Bowel Disease. Digestive Diseases and Sciences 53:10, pages 2746-2753.
Crossref
K. R. B. Oliveira, C. H. M. Castro, R. E. Heymann, M. M. Pinheiro, S. J. Mizsputen & V. L. Szejnfeld. (2007) High prevalence of fractures in Brazilian patients with inflammatory bowel disease: lack of association with bone mass density and quantitative ultrasound measurements. Archives of Osteoporosis 2:1-2, pages 21-28.
Crossref
Naomi Lee, Elizabeth Fowler, Susan Mason, Douglas Lincoln, Dennis R Taaffe & Graham Radford-Smith. (2007) Tumor necrosis factor-? haplotype is strongly associated with bone mineral density in patients with Crohn's disease. Journal of Gastroenterology and Hepatology 22:6, pages 913-919.
Crossref
Massimiliano Paganelli, Carlina Albanese, Osvaldo Borrelli, Fortunata Civitelli, Nicoletta Canitano, Franca Viola, Roberto Passariello & Salvatore Cucchiara. (2007) Inflammation Is The Main Determinant of Low Bone Mineral Density in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 13:4, pages 416-423.
Crossref
Gary R. Lichtenstein, Bruce E. Sands & Michael Pazianas. (2006) Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflammatory Bowel Diseases 12:8, pages 797-813.
Crossref
Sarah A Bartram. (2006) Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn’s disease. World Journal of Gastroenterology 12:35, pages 5680.
Crossref
Katja S Rothfuss, Eduard F Stange & Klaus R Herrlinger. (2006) Extraintestinal manifestations and complications in inflammatory bowel diseases. World Journal of Gastroenterology 12:30, pages 4819.
Crossref
Naomi Lee, Graham Radford-SmithDr.Dr. & Dennis R Taaffe. (2005) Bone Loss in Crohnʼs Disease: Exercise As a Potential Countermeasure. Inflammatory Bowel Diseases 11:12, pages 1108-1118.
Crossref
Nathalie Demerjian-Somogyi, Elisabeth Palazzo & Martine Cohen-Solal. (2005) Ostéoporose des maladies inflammatoires chroniques de l'intestin. Revue du Rhumatisme 72:9, pages 764-766.
Crossref
Nathalie Demerjian-Somogyi, Elisabeth Palazzo & Martine Cohen-Solal. (2005) Osteoporosis in patients with inflammatory bowel disease. Joint Bone Spine 72:5, pages 354-356.
Crossref
S. A. Bartram, R. T. Peaston, D. J. Rawlings, R. M. Francis & N. P. Thompson. (2003) A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Alimentary Pharmacology & Therapeutics 18:11-12, pages 1121-1127.
Crossref
Charles N. Bernstein, James F. Blanchard, Colleen Metge & Marina Yogendran. (2003) The association between corticosteroid use and development of fractures among IBD patients in a population-based database. The American Journal of Gastroenterology 98:8, pages 1797-1801.
Crossref
Charles N Bernstein & William D Leslie. (2003) The pathophysiology of bone disease in gastrointestinal disease. European Journal of Gastroenterology & Hepatology 15:8, pages 857-864.
Crossref
Karen L. Krok & Gary R. Lichtenstein. (2003) Nutrition in Crohn disease. Current Opinion in Gastroenterology 19:2, pages 148-153.
Crossref
Charles N. Bernstein, William D. Leslie & Meryl S. Leboff. (2003) AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124:3, pages 795-841.
Crossref
D.J. Jong, F.H.M. Corstens, L. Mannaerts, L.G.M. Rossum & A.H.J. Naber. (2002) Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?. The American Journal of Gastroenterology 97:8, pages 2011-2015.
Crossref
Edward V. LoftusJr.Jr., Cynthia S. Crowson, William J. Sandborn, William J. Tremaine, William M. O'Fallon & L.Joseph MeltonIIIIII. (2002) Long-term fracture risk in patients with Crohn's disease: A population-based study in Olmsted County, Minnesota. Gastroenterology 123:2, pages 468-475.
Crossref
Maria Cino & Gordon R. Greenberg. (2002) Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. The American Journal of Gastroenterology 97:4, pages 915-921.
Crossref
Aida Habtezion, Mark S. Silverberg, Robert Parkes, Shelley Mikolainis & A. Hillary Steinhart. (2002) Risk Factors for Low Bone Density in Crohn's Disease. Inflammatory Bowel Diseases 8:2, pages 87-92.
Crossref
Russell J. Clark, Phillip S. SizerJrJr & James Slauterbeck. (2017) Stress Fracture of the Ulna in a Male Competitive Polo Player. The American Journal of Sports Medicine 30:1, pages 130-132.
Crossref
K.L.E. DEAR, J.E. COMPSTON & J.O. HUNTER. (2001) Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clinical Nutrition 20:6, pages 541-546.
Crossref
William D. Leslie. (2001) All Patients with Inflammatory Bowel Disease Should Have Bone Density Assessment: Con. Inflammatory Bowel Diseases 7:2, pages 163-167.
Crossref
Claudia M.S. Schulte, Axel U. Dignass, Harald Goebell, Hans–Dietrich Röher & Klaus–Martin Schulte. (2000) Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 119:4, pages 909-920.
Crossref
K.V. Haderslev, L. Tjellesen, H.A. Sorensen & M. Staun. (2000) Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 119:3, pages 639-646.
Crossref
CAROL E. SEMRAD. (2006) Bone Mass and Gastrointestinal Disease. Annals of the New York Academy of Sciences 904:1, pages 564-570.
Crossref
Rivka Dresner-Pollak, Fanny Karmeli, Rami Eliakim, Zvi Ackerman & Daniel Rachmilewitz. (2000) Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. The American Journal of Gastroenterology 95:3, pages 699-704.
Crossref
Thomas P. Prindiville & Mary C. Cantrell. 2000. Nutrition and Immunology. Nutrition and Immunology 329 340 .
Edisio J. Semeao, Abbas F. Jawad, Nicole O. Stouffer, Babette S. Zemel, David A. Piccoli & Virginia A. Stallings. (1999) Risk factors for low bone mineral density in children and young adults with Crohn’s disease. The Journal of Pediatrics 135:5, pages 593-600.
Crossref
M Dinca, W Fries, G Luisetto, F Peccolo, F Bottega, L Leone, R Naccarato & A Martin. (1999) Evolution of Osteopenia in Inflammatory Bowel Disease. American Journal of Gastroenterology 94:5, pages 1292-1297.
Crossref
Zeljka Crncevic Orlic & Lawrence G. Raisz. (1999) Causes of Secondary Osteoporosis. Journal of Clinical Densitometry 2:1, pages 79-92.
Crossref
J. Stein & F. Menge. 1999. Darmkrankheiten. Darmkrankheiten 683 693 .
M. De Vos, F. De Keyser, Mielants, Cuvelier & Veys. (1998) Bone and joint diseases in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 12:5, pages 397-404.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.